• Skip to content
  • Skip to footer
McKesson logo'); McKesson
  • About Us
  • Our Stories
  • Careers
  • Investors
  • Contact Us
  • Logins
Solutions  right arrow
  • Pharmaceutical Distribution
    Overview
    Ordering
    • Drug Ordering for Pharmacies
    • Specialty Drugs for Physician Practices
    • Plasma & Biologics for Non-Physicians
    • Brand Name Drugs
    • Generic Drugs
    • Vaccines
    • OTC Pharmacy Products
    • Controlled Substance Ordering (CSOS)
    Packaging Solutions
    • Drug Packaging Services
  • Wholesale Medical Supplies
    Overview
    Supplies & Equipment
    • Post Acute Care Supplies
    • Surgery Center Supplies & Equipment
    • Physician Supplies
    • Non-Acute Supplies
    • Lab Supplies & Equipment
    • Home Medical Equipment
    • Emergency Medical Products
    • Flu Vaccines
    Ordering Platform
    • SupplyManager Medical Supply Ordering
  • Pharmacy Services & Technology
    Overview
    Pharmacy Ownership
    • Pharmacy Ownership Consulting
    • Health Mart Franchise Program
    Health Systems
    • Consulting & Software Solutions
    • Prescribed Perspectives
    Contract Management
    • Health Mart Atlas
    • McKesson Specialty Network
    Business Operations
    • Pharmacy Management Software
    • Pharmacy Operations
    • Pharmacy Automation Solutions
    • Drug Purchasing Management
    • Pharmacy Group Purchasing
    • Pharmacy Claims Reimbursement
    • Audit Risk Mitigation
    • Patient Adherence & Wellness
    • Alternate Site Pharmacy Solutions
  • Solutions for Specialty Practices
    Top Solutions
    • Specialties We Support
    • Drug Purchasing and Management
    • Advisors and Tools
    • Oncology Clinical Management Technology
    • Full-Service Practice Management
  • Solutions for Biopharma
    Overview
    • Resources
    Supply Chain Solutions
    • Distribution Services
    • Third Party Logistics
    Drug Development & Regulatory Affairs
    • Clinical Trials Services
    Patient Services
    • Specialty Pharmacy
    Data, Evidence & Insights
    • Oncology Real-World Evidence
      & Provider Engagement
    Commercial Services
    • Access & Adherence
    • Program Pharmacy
    • LoyaltyScript Co-Pay Program
    • eVoucherRx Co-Pay Savings
All Solutions
Pharmaceutical Distributionright arrow
  • Overview
Ordering
  • Drug Ordering for Pharmacies
  • Specialty Drugs for Physician Practices
  • Plasma & Biologics for Non-Physicians
  • Brand Name Drugs
  • Generic Drugs
  • Vaccines
  • OTC Pharmacy Products
  • Controlled Substance Ordering (CSOS)
Packaging Solutions
  • Drug Packaging Services
Wholesale Medical Suppliesright arrow
  • Overview
Supplies & Equipment
  • Post Acute Care Supplies
  • Surgery Center Supplies & Equipment
  • Physician Supplies
  • Non-Acute Supplies
  • Lab Supplies & Equipment
  • Home Medical Equipment
  • Emergency Medical Products
  • Flu Vaccines
Ordering Platform
  • SupplyManager Medical Supply Ordering
Pharmacy Services & Technologyright arrow
  • Overview
Pharmacy Ownership
  • Pharmacy Ownership Consulting
  • Health Mart Franchise Program
Health Systems
  • Consulting & Software Solutions
  • Prescribed Perspectives
Contract Management
  • Health Mart Atlas
  • McKesson Specialty Network
Business Operations
  • Pharmacy Management Software
  • Pharmacy Operations
  • Pharmacy Automation Solutions
  • Drug Purchasing Management
  • Pharmacy Group Purchasing
  • Pharmacy Claims Reimbursement
  • Audit Risk Mitigation
  • Patient Adherence & Wellness
  • Alternate Site Pharmacy Solutions
Solutions for Specialty Practicesright arrow
Top Solutions
  • Specialties We Support
  • Drug Purchasing and Management
  • Advisors and Tools
  • Oncology Clinical Management Technology
  • Full-Service Practice Management
Solutions for Biopharmaright arrow
  • Overview
  • Resources
Supply Chain Solutions
  • Distribution Services
  • Third Party Logistics
Drug Development & Regulatory Affairs
  • Clinical Trials Services
Patient Services
  • Specialty Pharmacy
Data, Evidence & Insights
  • Oncology Real-World Evidence
    & Provider Engagement
Commercial Services
  • Access & Adherence
  • Program Pharmacy
  • LoyaltyScript Co-Pay Program
  • eVoucherRx Co-Pay Savings
More right arrow
  •  
  • 1
  • 2
  •  
  • February 01, 2023

    McKesson Corporation Reports Fiscal 2023 Third-Quarter Results and Raises Full-Year Guidance

    Keywords: Corporate, Earnings, Investors, Corporate

  • January 26, 2023

    McKesson Declares Quarterly Dividend

    Keywords: Corporate, Earnings, Investors, Corporate

  • January 23, 2023

    McKesson Receives Approval of Its Near-term Climate Change Targets by the Globally Recognized Science Based Targets initiative

    Keywords: COVID-19, Corporate, Chronic Care Management, McKesson Ventures, Providers, Consumers, Community Days, Electronic Health Records, M&A, Earnings, Disease Management, Picture Archive Communications System, Health Mart, Electronic Prescribing, Computerized Physician Order Entry, Revenue Cycle Management, Patient Safety, US Oncology, Pharmaceutical Distribution, Pharmacies, Nurses, Manufacturers, Investors, Healthcare Providers, Corporate

  • January 17, 2023

    The US Oncology Network Continues its Rapid Growth into New Communities, Adding Epic Care and Nexus Health

    Keywords: US Oncology Network, Pharmaceutical Solutions & Services, Providers, Consumers, US Oncology, Healthcare Providers

  • December 28, 2022

    McKesson Corporation Announces Third-Quarter Fiscal 2023 Earnings Release Date

    Keywords: Corporate, Earnings, Investors, Corporate

  • December 22, 2022

    FYARRO (sirolimus protein-bound particles for injectable suspension) (albumin-bound), FDA Approved for Treatment of Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor, Available at Biologics by McKesson

    Keywords: Pharmaceutical Solutions & Services, Providers, Pharmaceutical Distribution, Manufacturers, McKesson Pharmacy Systems

  • December 19, 2022

    REZLIDHIA (olutasidenib), FDA-Approved for Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia, Available at Biologics by McKesson

    Keywords: Pharmaceutical Solutions & Services, Providers, Pharmaceutical Distribution, Manufacturers, McKesson Pharmacy Systems

  • December 14, 2022

    KRAZATI® (adagrasib), FDA Approved for Treatment of Advanced Non-Small Cell Lung Cancer Harboring the KRASG12C Mutation, Available at Biologics by McKesson

    Keywords: Pharmaceutical Solutions & Services, Providers, Pharmaceutical Distribution, Manufacturers, McKesson Pharmacy Systems

  • December 12, 2022

    ELAHERE™ (mirvetuximab soravtansine-gynx), FDA Approved for Platinum-Resistant Ovarian Cancer, Available at Biologics by McKesson

    Keywords: Pharmaceutical Solutions & Services, McKesson Plasma & Biologics, Providers, Pharmaceutical Distribution, Pharmacies

  • November 07, 2022

    McKesson Foundation Awards $4.1 Million to Pharmacy Schools to Help Close Diversity Gap and Improve Health Outcomes

    Keywords: Corporate, Providers, Consumers, Health Mart, Pharmacies, Nurses, Manufacturers, Investors, Healthcare Providers, Corporate

  • November 01, 2022

    McKesson Corporation Reports Fiscal 2023 Second-Quarter Results and Raises Full-Year Guidance

    Keywords: Corporate, Earnings, Investors, Corporate

  • October 27, 2022

    McKesson Corporation Declares Quarterly Dividend

    Keywords: Corporate, Earnings, Investors, Corporate

  • October 26, 2022

    McKesson Opens Its Most Technologically Advanced Healthcare Distribution Center in Jeffersonville, Ohio

    Keywords: PSS-Retail Pharmacy, Consumers, Pharmaceutical Distribution, Pharmacies, Manufacturers, Investors, Healthcare Providers, Corporate

  • October 18, 2022

    McKesson Thought Leaders Are Key Presenters at 2022 Association for Value-Based Cancer Care Summit

    Keywords: US Oncology Network, PSS-The US Oncology Network, Providers, US Oncology

  • September 29, 2022

    McKesson Corporation Extends Pharmaceutical Distribution Agreement with CVS Health

    Keywords: Corporate, Earnings, Investors, Corporate

  • September 19, 2022

    McKesson Signs Agreement to Acquire Rx Savings Solutions

    Keywords: Corporate, Chronic Care Management, Providers, Consumers, Disease Management, Electronic Prescribing, Pharmaceutical Distribution, Pharmacies, Investors, Healthcare Providers, Corporate

  • September 13, 2022

    McKesson Names LeAnn B. Smith as Next Chief Human Resources Officer

    Keywords: COVID-19, Corporate, Chronic Care Management, McKesson Ventures, Providers, Consumers, Community Days, Electronic Health Records, M&A, Earnings, Disease Management, Picture Archive Communications System, Health Mart, Electronic Prescribing, Computerized Physician Order Entry, Revenue Cycle Management, Patient Safety, US Oncology, Pharmaceutical Distribution, Pharmacies, Nurses, Manufacturers, Investors, Healthcare Providers, Corporate

  • August 04, 2022

    McKesson Medical-Surgical Supports National Health Center Week 2022

    Keywords: McKesson Medical-Surgical, Providers, Consumers, Community Days, Pharmacies, Nurses, Manufacturers, Investors, Healthcare Providers, McKesson Medical-Surgical

  • August 03, 2022

    McKesson Corporation Reports Fiscal 2023 First-Quarter Results

    Keywords: Corporate, Earnings, Investors, Corporate

  • July 25, 2022

    McKesson Raises Quarterly Dividend by 15% to $0.54 Per Share

    Keywords: Corporate, Earnings, Investors, Corporate

  • July 25, 2022

    Biologics by McKesson is now the Exclusive Specialty Pharmacy Provider of XERMELO (telotristat ethyl), an FDA Approved Therapy for Carcinoid Syndrome Diarrhea

    Keywords: Pharmaceutical Solutions & Services, Pharmaceutical Distribution, Pharmacies, McKesson Pharmacy Systems

  • July 20, 2022

    McKesson Earns Top Score as One of the Best Places to Work for Disability Inclusion

    Keywords: Corporate, Chronic Care Management, McKesson Ventures, Providers, Consumers, Community Days, Electronic Health Records, M&A, Earnings, Disease Management, Picture Archive Communications System, Health Mart, Electronic Prescribing, Computerized Physician Order Entry, Revenue Cycle Management, Patient Safety, US Oncology, Pharmaceutical Distribution, Pharmacies, Nurses, Manufacturers, Investors, Healthcare Providers, Corporate

  • July 12, 2022

    McKesson ideaShare Conference Draws Attendees From More Than 2,100 Independent Pharmacies to First In-Person Conference Since 2019

    Keywords: Pharmaceutical Solutions & Services, McKesson Pharmacy Systems, Health Mart, Pharmacies, McKesson Pharmacy Systems

  • June 29, 2022

    McKesson Corporation Announces First Quarter Fiscal 2023 Earnings Release Date

    Keywords: Corporate, Earnings, Investors, Corporate

  • June 23, 2022

    McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture to Advance Cancer Care and Increase Access to Oncology Clinical Research

    Keywords: US Oncology Network, PSS-The US Oncology Network, Corporate, Providers, Disease Management, US Oncology, Nurses, Healthcare Providers, Corporate

  • June 06, 2022

    New MYLUNG Consortium Research Demonstrates Remote Pharmacist Intervention Significantly Increases Clinical Trial Enrollments in Community Oncology Setting

    Keywords: US Oncology Network, Ontada, PSS-The US Oncology Network, US Oncology, Pharmacies, Manufacturers

  • June 03, 2022

    Investigators from US Oncology Research, The US Oncology Network and Ontada Present Data Highlighting Key Advances and Insights at the 2022 American Society of Clinical Oncology Annual Meeting

    Keywords: US Oncology Network, Ontada, PSS-The US Oncology Network, US Oncology, Pharmacies, Manufacturers, Healthcare Providers

  • May 05, 2022

    McKesson Reports Fiscal 2022 Fourth Quarter and Full-Year Results

    Keywords: Corporate, Earnings, Investors, Corporate

  • May 03, 2022

    Distributors Agree to Opioid Settlement with Washington State

    Keywords: Corporate, Investors, Corporate

  • April 28, 2022

    McKesson Declares Quarterly Dividend

    Keywords: Corporate, Earnings, Investors, Corporate

  • April 07, 2022

    McKesson Corporation Completes Divestiture of UK Businesses, Announces Fourth Quarter Fiscal 2022 Earnings Release Date

    Keywords: Corporate, Earnings, Investors, Corporate

  • April 01, 2022

    McKesson’s Board of Directors Elects W. Roy Dunbar as New Director

    Keywords: Corporate, Chronic Care Management, McKesson Ventures, Community Days, Electronic Health Records, M&A, Earnings, Disease Management, Picture Archive Communications System, Health Mart, Electronic Prescribing, Computerized Physician Order Entry, Revenue Cycle Management, Patient Safety, US Oncology, Pharmaceutical Distribution, Investors, Corporate

  • March 14, 2022

    McKesson Supports Ukraine Relief Efforts

    Keywords: Corporate, Corporate

  • March 14, 2022

    VONJO (pacritinib), FDA Approved for Treatment of Intermediate or High-risk Myelofibrosis, Available at Biologics by McKesson

    Keywords: Pharmaceutical Solutions & Services, Pharmaceutical Distribution, Manufacturers, McKesson Pharmacy Systems

  • March 02, 2022

    PYRUKYND (mitapivat), FDA Approved for Treatment of Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency, Available Exclusively at Biologics by McKesson

    Keywords: Pharmaceutical Solutions & Services, Pharmaceutical Distribution, Manufacturers, McKesson Pharmacy Systems

  • February 25, 2022

    Distributors Approve Opioid Settlement Agreement

    Keywords: Corporate, Pharmaceutical Distribution, Manufacturers, Investors, Corporate

  • February 08, 2022

    McKesson Designated by CMS as 2022 Qualified Clinical Data Registry

    Keywords: US Oncology Network, Ontada, Ontada, PSS-The US Oncology Network, Corporate, Providers, US Oncology, Healthcare Providers, Corporate

  • February 07, 2022

    Ontada Names Dr. Nicholas Robert as Chief Medical Officer

    Keywords: Ontada, Ontada

  • February 02, 2022

    McKesson Reports Fiscal 2022 Third Quarter-Results

    Keywords: Corporate, Earnings, Investors, Corporate

  • January 27, 2022

    McKesson Declares Quarterly Dividend

    Keywords: Corporate, Earnings, Investors, Corporate

  • January 27, 2022

    McKesson Recognized as one of the “Best Places to Work for LGBTQ+ Equality” for Ninth Year in a Row

    Keywords: Corporate, Chronic Care Management, McKesson Ventures, Consumers, Community Days, Electronic Health Records, M&A, Earnings, Disease Management, Picture Archive Communications System, Health Mart, Electronic Prescribing, Computerized Physician Order Entry, Revenue Cycle Management, Patient Safety, US Oncology, Pharmaceutical Distribution, Corporate

  • January 25, 2022

    Ontada Names Viraj Narayanan as Chief Commercial Officer

    Keywords: Ontada, Ontada

  • January 18, 2022

    McKesson’s Board of Directors Elects James H. Hinton and Kathleen Wilson-Thompson as New Directors

    Keywords: Corporate, Corporate

  • December 29, 2021

    McKesson Corporation Announces Third Quarter Fiscal 2022 Earnings Release Date and Participation in January Conference

    Keywords: Corporate, Earnings, Investors, Corporate

  • December 22, 2021

    Distributors Announce Extension of Opioid Settlement Sign-On Period, Participation of New Mexico

    Keywords: Corporate, Corporate

  • December 22, 2021

    TARPEYOTM (budesonide) delayed release capsules, FDA Approved to Reduce Proteinuria in IgA Nephropathy, Available Exclusively at Biologics by McKesson

    Keywords: PSS-McKesson Plasma & Biologics, McKesson Plasma & Biologics, Providers, Pharmaceutical Distribution, Manufacturers

  • December 20, 2021

    McKesson Corporation Enters Agreement to Sell its Austrian Business to Quadrifolia Management GmbH

    Keywords: Corporate, Investors, Corporate

  • December 09, 2021

    US Oncology Research, The US Oncology Network and Ontada Announce Data Presentations across Areas of Critical Need at 2021 American Society of Hematology Annual Meeting and Exposition

    Keywords: Pharmaceutical Solutions & Services, Providers, US Oncology, Manufacturers, McKesson Pharmacy Systems

  • December 08, 2021

    McKesson Investor Day to Highlight Progress Against Growth Strategies and Long-Term Financial Targets

    Keywords: Corporate, Earnings, Corporate

  • December 06, 2021

    BESREMi (ropeginterferon alfa-2b-njft), FDA Approved for Treatment of Polycythemia Vera, Available at Biologics by McKesson

    Keywords: Corporate, Providers, Pharmaceutical Distribution, Pharmacies, Manufacturers, Corporate

  • December 03, 2021

    Newly Approved LIVTENCITY (maribavir) Now Available at Biologics by McKesson

    Keywords: Pharmaceutical Solutions & Services, Providers, Pharmaceutical Distribution, Manufacturers, McKesson Pharmacy Systems

  • December 01, 2021

    McKesson to Host Investor Day on December 8, 2021

    Keywords: Corporate, Earnings, Investors, Corporate

  • November 30, 2021

    Walgreens Boots Alliance Acquires Remaining Stake in German GEHE-Alliance Healthcare Joint Venture From McKesson

    Keywords: Corporate, Investors, Corporate

  • November 16, 2021

    New Metrics Show The US Oncology Network Practices Leading the Way in Value-Based Care

    Keywords: US Oncology Network, PSS-The US Oncology Network, Providers, US Oncology

  • November 04, 2021

    McKesson Opens State-of-the-Art Distribution Center in Michigan

    Keywords: Corporate, McKesson U.S. Pharmaceutical, Providers, Consumers, Pharmaceutical Distribution, Pharmacies, Nurses, Manufacturers, Investors, Healthcare Providers, Corporate

  • November 03, 2021

    Ontada Names Sagran Moodley as Chief Innovation and Technology Officer

    Keywords: Ontada, Ontada

  • November 03, 2021

    EXKIVITY (mobocertinib), First and Only FDA Approved Oral Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer, Available at Biologics by McKesson

    Keywords: Pharmaceutical Solutions & Services, Corporate, Pharmaceutical Distribution, Pharmacies, Manufacturers, McKesson Pharmacy Systems, Corporate

  • November 01, 2021

    McKesson Reports Fiscal 2022 Second-Quarter Results

    Keywords: Corporate, Earnings, Investors, Corporate

  • November 01, 2021

    McKesson Corporation Enters Agreement to Sell UK Businesses to AURELIUS

    Keywords: Corporate, Corporate

  • October 28, 2021

    McKesson Declares Quarterly Dividend

    Keywords: Corporate, Earnings, Investors, Corporate

  • October 20, 2021

    Health Mart Unveils Digital Portfolio for Community Pharmacies

    Keywords: PSS-Health Mart, Health Mart, Consumers, Health Mart, Pharmacies

  • September 28, 2021

    Distributors Announce Settlement with Cherokee Nation

    Keywords: Corporate, Corporate

  • September 27, 2021

    McKesson Corporation to Announce Second Quarter Fiscal 2022 Results on November 1, 2021

    Keywords: Corporate, Earnings, Investors, Corporate

  • September 20, 2021

    Hayat Pharmacy Named Health Mart Pharmacy of the Year

    Keywords: PSS-Health Mart, Health Mart, Health Mart

  • September 20, 2021

    The US Oncology Network Announces Trusted Leader Jason Hammonds as New President

    Keywords: US Oncology Network, PSS-The US Oncology Network, US Oncology

  • September 16, 2021

    McKesson Launches Rapid Returns Solution for Health Systems

    Keywords: Corporate, Pharmacies, Healthcare Providers, Corporate

  • September 15, 2021

    Ontada Launches HOPE Studies, Empowering Oncologists to Leverage Real-World Data and Address Healthcare Disparities

    Keywords: Ontada, Ontada, Corporate, US Oncology

  • September 07, 2021

    McKesson’s Board of Directors Elects Dr. Richard H. Carmona as New Independent Director

    Keywords: Corporate, Corporate

  • September 04, 2021

    Distributors Announce Proposed Opioid Settlement Will Proceed to Next Phase

    Keywords: Corporate, Corporate

  • August 26, 2021

    Ontada Signs Strategic Agreement with Merck to Facilitate the Development of Data-Driven Insights to Impact Quality of Cancer Care

    Keywords: Ontada, Ontada, Corporate, Corporate

  • August 24, 2021

    McKesson ideaShare to Bring Together 2,000 Community Pharmacies Virtually

    Keywords: Corporate, Health Mart, Health Mart, Pharmacies, Corporate

  • August 20, 2021

    WELIREGTM (belzutifan), FDA Approved, Available at Biologics by McKesson

    Keywords: Corporate, Chronic Care Management, Providers, Manufacturers, Corporate

  • August 16, 2021

    McKesson to Host Investor Day on December 8, 2021

    Keywords: Corporate, Investors, Corporate

  • August 04, 2021

    McKesson Reports Fiscal 2022 First-Quarter Results

    Keywords: Corporate, Earnings, Investors, Corporate

  • July 30, 2021

    REZUROCK (belumosudil) tablets, FDA Approved for Treatment of Chronic Graft-Versus-Host Disease, Available at Biologics by McKesson

    Keywords: Corporate, Pharmaceutical Distribution, Manufacturers, Corporate

  • July 26, 2021

    McKesson Raises Quarterly Dividend by 12% to $0.47 Per Share

    Keywords: Corporate, Earnings, Investors, Corporate

  • July 22, 2021

    McKesson Corporation Announces Pricing and Upsizing of Tender Offer

    Keywords: Corporate, Investors, Corporate

  • July 22, 2021

    McKesson Corporation Announces Early Tender Results and Intention to Increase the Tender Cap

    Keywords: Corporate, Earnings, Investors, Corporate

  • July 21, 2021

    Distributors Announce Proposed Opioid Settlement Agreement

    Keywords: Corporate, Corporate

  • July 20, 2021

    Distributors Reach Opioid Settlement with New York State

    Keywords: Corporate

  • July 13, 2021

    McKesson Named One of the Best Places to Work for Disability Inclusion

    Keywords: Corporate, Corporate

  • July 08, 2021

    McKesson Corporation Announces Offer to Purchase $500 Million Aggregate Principal Amount of Debt

    Keywords: Corporate, Corporate

  • July 07, 2021

    McKesson Corporation Enters Agreement to Sell Certain European Businesses to the PHOENIX Group

    Keywords: Corporate, Corporate

  • June 30, 2021

    McKesson Corporation to Announce First Quarter Fiscal 2022 Results on August 4, 2021

    Keywords: Corporate, Earnings, Investors, Corporate

  • June 21, 2021

    TRUSELTIQ (infigratinib), FDA Approved for Treatment of Cholangiocarcinoma, Available at Biologics by McKesson

    Keywords: Corporate, Disease Management, Corporate

  • June 11, 2021

    LUMAKRAS (sotorasib), FDA Approved for Treatment of KRAS G12C-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer, Available at Biologics by McKesson

    Keywords: Corporate, Disease Management, Corporate

  • June 04, 2021

    First Phase Results of MYLUNG Consortium Provide Historical View of Biomarker Testing Patterns and Identify Data Gaps for Ongoing Prospective Research

    Keywords: US Oncology Network, PSS-The US Oncology Network, US Oncology

  • June 03, 2021

    US Oncology Research, The US Oncology Network and Ontada Announce Clinical Data Showcased in Plenary and Oral Sessions at ASCO Annual Meeting

    Keywords: US Oncology Network, PSS-The US Oncology Network, Corporate, US Oncology, Corporate

  • May 19, 2021

    Community Pharmacies with Health Mart, Health Mart Atlas Administer 1 Million COVID-19 Vaccine Doses

    Keywords: COVID-19, PSS-Health Mart, Corporate, Health Mart, Providers, Health Mart, Pharmacies, Healthcare Providers

  • May 06, 2021

    McKesson Reports Fiscal 2021 Fourth-Quarter Results and Full-Year Results

    Keywords: Corporate, Earnings, Investors, Corporate

  • May 05, 2021

    McKesson Commits to Set Science-Based Targets to Reduce Greenhouse Gas Emissions

    Keywords: Corporate, Corporate

  • April 29, 2021

    McKesson Declares Quarterly Dividend

    Keywords: Corporate, Earnings, Investors

  • April 19, 2021

    McKesson Announces N. Anthony Coles, M.D. Will Not Stand for Re-Election to McKesson Board of Directors

    Keywords: Corporate, Corporate

  • April 19, 2021

    NULIBRY (fosdenopterin), First and Only FDA-Approved Therapy to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency Type A, Available Exclusively at Biologics by McKesson

    Keywords: Corporate, Disease Management, Pharmaceutical Distribution, Pharmacies, Corporate

  • April 01, 2021

    McKesson Corporation to Announce Fourth Quarter Fiscal 2021 Results on May 6, 2021

    Keywords: Corporate, Earnings, Investors, Corporate

  • April 01, 2021

    The US Oncology Network continues its rapid growth and enhances surgical expertise with addition of physicians from Texas Colon & Rectal Specialists as a part of Texas Oncology

    Keywords: US Oncology Network, PSS-The US Oncology Network, US Oncology

  • March 25, 2021

    McKesson Approved as QCDR for 2021 MIPS Program Year

    Keywords: US Oncology Network, Ontada, Ontada, PSS-The US Oncology Network, Corporate, US Oncology, Corporate

  • March 22, 2021

    Ontada Appoints Susan Shiff, Ph.D., MBA, as President

    Keywords: Ontada, Ontada, Corporate, Corporate

  • March 18, 2021

    McKesson launches ScriptPAS, empowering oncology practices to reduce time to therapy while enhancing patient care

    Keywords: Corporate, Providers, Corporate

  • March 16, 2021

    McKesson Expands Integrated Pharmacy Services for Specialty Clinics

    Keywords: Corporate, Pharmacies, Corporate

  • March 12, 2021

    FOTIVDA (tivozanib), FDA Approved for Treatment of Relapsed/Refractory Advanced Renal Cell Carcinoma, Available at Biologics by McKesson

    Keywords: Corporate, Providers, Pharmacies, Corporate

  • March 01, 2021

    McKesson Begins Distributing the Johnson & Johnson COVID-19 Vaccine

    Keywords: COVID-19, Corporate, Providers, Consumers, Pharmacies, Manufacturers, Corporate

  • February 18, 2021

    Ontada’s Clear Value Plus Provides 800,000th Chemotherapy Treatment Decision

    Keywords: US Oncology Network, Corporate, Corporate

  • February 11, 2021

    McKesson RxOwnership Expands Commitment to Pharmacy Owners

    Keywords: Corporate, Corporate

  • February 04, 2021

    MYLUNG Study Launches, Aiming to Advance Use of Precision Medicine for Metastatic Non-Small Cell Lung Cancer Patients

    Keywords: Corporate, Providers, US Oncology, Corporate

  • February 02, 2021

    McKesson Reports Fiscal 2021 Third-Quarter Results

    Keywords: Corporate, Earnings, Investors, Corporate

  • January 28, 2021

    McKesson Recognized as one of the “Best Places to Work for LGBTQ Equality” for Eighth Year in a Row

    Keywords: Corporate, Corporate

  • January 28, 2021

    McKesson Declares Quarterly Dividend

    Keywords: Corporate, Earnings, Investors, Corporate

  • January 21, 2021

    ORGOVYX (relugolix), the First FDA-Approved Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer, Available at Biologics by McKesson

    Keywords: Corporate, Corporate

  • January 15, 2021

    McKesson Statement on Political Contributions

    Keywords: Corporate, Corporate

  • December 28, 2020

    McKesson Corporation Announces Third Quarter Fiscal 2021 Earnings Release Date and Participation in January Conferences

    Keywords: Corporate, Earnings, Investors, Corporate

  • December 20, 2020

    McKesson Fills Initial Government Orders for Moderna’s COVID-19 Vaccine

    Keywords: COVID-19, Corporate, Corporate

  • December 16, 2020

    McKesson and TailorMed Collaborate to Reduce Patient Financial Barriers to Care

    Keywords: Corporate, Corporate

  • December 04, 2020

    Amgen and McKesson Launch Strategic Agreement to Advance Cancer Innovation in Communities

    Keywords: Corporate, Corporate

  • December 03, 2020

    McKesson Launches Ontada, an Oncology Technology and Insights Business Dedicated to Help Advance Cancer Research and Care

    Keywords: Corporate, Corporate

  • December 02, 2020

    US Oncology Research Announces Schedule of Presentations at the Virtual 2020 American Society of Hematology Annual Meeting and Exposition

    Keywords: US Oncology Network, PSS-The US Oncology Network, US Oncology

  • November 19, 2020

    McKesson Appoints Dr. Kelvin A. Baggett to Chief Impact Officer

    Keywords: Corporate, Corporate

  • November 11, 2020

    The US Oncology Network Enrolls 100,000th Patient in the Oncology Care Model, Enhancing Care While Saving Medicare over $100 Million

    Keywords: US Oncology Network, PSS-The US Oncology Network, US Oncology

  • November 10, 2020

    McKesson Joins United Nations Global Compact Initiative

    Keywords: Corporate, Corporate

  • November 03, 2020

    McKesson Reports Fiscal 2021 Second-Quarter Results

    Keywords: Corporate, Earnings, Investors, Corporate

  • November 02, 2020

    Walgreens Boots Alliance and McKesson Complete the Formation of German Wholesale Joint Venture

    Keywords: Corporate, Corporate

  • October 29, 2020

    McKesson Declares Quarterly Dividend

    Keywords: Corporate, Earnings, Investors, Corporate

  • October 27, 2020

    Providing Care in a Pandemic and Beyond: Three Considerations for Hospital Leaders

    Keywords: Corporate, Corporate

  • October 22, 2020

    The US Oncology Network continues to grow, enhancing community cancer care by welcoming two more practices

    Keywords: US Oncology Network, PSS-The US Oncology Network, US Oncology

  • October 19, 2020

    McKesson’s Board of Directors Elects Linda Mantia as New Independent Director

    Keywords: Corporate, Corporate

  • October 06, 2020

    Dr. Robert L. Coleman Named an OncLive Giant of Cancer Care

    Keywords: US Oncology Network, PSS-The US Oncology Network, Corporate, US Oncology

  • October 05, 2020

    McKesson Corporation to Announce Second Quarter Fiscal 2021 Results on November 3, 2020

    Keywords: Corporate, Earnings, Investors, Corporate

  • September 30, 2020

    Elevation Oncology and US Oncology Research Announce Collaboration to Expand Genomic Testing of Solid Tumors and Local Site Activation in Support of the Phase 2 CRESTONE Study

    Keywords: US Oncology Network, PSS-The US Oncology Network, Providers, US Oncology

  • September 29, 2020

    US Oncology Research Achieves Milestone of over 100 FDA-Approved Cancer Therapies

    Keywords: US Oncology Network, PSS-The US Oncology Network, Providers, US Oncology

  • September 23, 2020

    ValuCare Center Named Health Mart Pharmacy of the Year

    Keywords: Corporate, Health Mart, Corporate

  • September 17, 2020

    Health Mart Pharmacies Fight Flu to Protect Patients

    Keywords: Corporate, Health Mart, Corporate

  • September 17, 2020

    GAVRETO (pralsetinib), FDA Approved for Treatment of Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer, Available at Biologics by McKesson

    Keywords: Corporate, Corporate

  • September 16, 2020

    McKesson Ventures Grows Leadership Team with New Partner Promotions

    Keywords: Corporate, McKesson Ventures, Corporate

  • September 02, 2020

    Health Mart Receives Pharmacy Technician Training Program Accreditation

    Keywords: PSS-Health Mart, Health Mart, Health Mart, Pharmacies

  • August 24, 2020

    INQOVI (decitabine and cedazuridine) Tablets, FDA Approved for Treatment of Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia, Available at Biologics by McKesson

    Keywords: Corporate, Corporate

  • August 18, 2020

    McKesson Named to the Diversity Best Practices Inclusion Index

    Keywords: Corporate, Corporate

  • August 14, 2020

    McKesson to Distribute Future COVID-19 Vaccines in Support of Operation Warp Speed

    Keywords: Corporate, Corporate

  • August 10, 2020

    McKesson Canada names Rebecca McKillican Chief Executive Officer

    Keywords: Corporate, Corporate

  • August 10, 2020

    Supplylogix to Help Pharmacy Customers Track Inventory Movement with Pinpoint Order Update

    Keywords: Corporate, Corporate

  • August 04, 2020

    The US Oncology Network Names Vivek Kavadi, MD, Chief Radiation Oncologist

    Keywords: US Oncology Network, PSS-The US Oncology Network, Providers, US Oncology

  • August 03, 2020

    McKesson Reports Fiscal 2021 First-Quarter Results

    Keywords: Corporate, Earnings, Investors, Corporate

  • July 29, 2020

    McKesson Declares Quarterly Dividend July 29, 2020

    Keywords: Corporate, Earnings, Investors, Corporate

  • July 16, 2020

    McKesson Named One of the Best Places to Work for Disability Inclusion

    Keywords: Corporate, Corporate

  • July 06, 2020

    McKesson Corporation to Announce First Quarter Fiscal 2021 Results on August 3, 2020

    Keywords: Corporate, Investors, Corporate

  • July 01, 2020

    McKesson Realigns Organizational Structure to Better Serve Customers and Patients While Optimizing Growth

    Keywords: Corporate, Corporate

  • June 29, 2020

    XPOVIO (selinexor), FDA Approved for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL), Available at Biologics by McKesson

    Keywords: Corporate, Corporate

  • June 05, 2020

    Preliminary Research Involving Members of The US Oncology Network Finds Cancer Drug May Benefit Advanced COVID-19 Patients

    Keywords: US Oncology Network, PSS-The US Oncology Network

  • June 04, 2020

    McKesson Appoints Tom Rodgers to Executive Vice President & Chief Strategy and Business Development Officer

    Keywords: Corporate, McKesson Ventures, Corporate

  • June 04, 2020

    QINLOCK (Ripretinib), FDA Approved for Treatment of Gastrointestinal Stromal Tumors (GIST), Available at Biologics by McKesson

    Keywords: Corporate, Corporate

  • June 02, 2020

    RETEVMO (selpercatinib), FDA-Approved for Treatment of RET-driven Lung and Thyroid Cancers, Available at Biologics by McKesson

    Keywords: Corporate, Corporate

  • May 28, 2020

    Investigators from US Oncology Research and McKesson Present Data Highlighting Key Advances in Oncology Research at the 2020 American Society of Clinical Oncology Annual Meeting and Exposition

    Keywords: US Oncology Network, PSS-The US Oncology Network

  • May 27, 2020

    Pemazyre (pemigatinib) Available Exclusively at Biologics by McKesson

    Keywords: Corporate, Corporate

  • May 20, 2020

    McKesson Reports Fiscal 2020 Fourth-Quarter and Full-Year Results

    Keywords: Corporate, Earnings, Investors, Corporate

  • May 12, 2020

    Health Mart Pharmacies Launch COVID-19 Test Collection Sites

    Keywords: PSS-Health Mart, Health Mart, Health Mart

  • May 11, 2020

    TRODELVY (sacituzumab govitecan-hziy), FDA Approved for Treatment of Metastatic Triple-negative Breast Cancer, Available Only at Biologics by McKesson

    Keywords: Corporate, Corporate

  • May 05, 2020

    McKesson Appoints Lyn Fitzgerald as Vice President of Sales for McKesson Data, Evidence & Insights

    Keywords: Corporate

  • April 29, 2020

    McKesson Declares Quarterly Dividend

    Keywords: Corporate, Earnings, Investors, Corporate

  • April 20, 2020

    McKesson Corporation to Announce Fourth Quarter Fiscal 2020 Results on May 20, 2020

    Keywords: Corporate, Earnings, Investors, Corporate

  • April 20, 2020

    TUKYSA (tucatinib), FDA Approved for Treatment of Advanced Unresectable or Metastatic HER2 Positive Breast Cancer, Available at Biologics by McKesson

    Keywords: Corporate, Corporate

  • March 31, 2020

    The US Oncology Network names renowned cancer researcher Robert L. Coleman, MD, Chief Scientific Officer

    Keywords: US Oncology Network

  • March 23, 2020

    McKesson Announces Bansi Nagji to Step Down as Executive Vice President, Chief Strategy and Business Development Officer

    Keywords: Corporate, Corporate

  • March 19, 2020

    DOPTELET (avatrombopag) Now Available at Biologics by McKesson

    Keywords: Corporate, Corporate

  • March 17, 2020

    McKesson Updates Fiscal 2020 Guidance Following Completion of Change Healthcare Split-Off

    Keywords: Corporate, Earnings, Investors, Corporate

  • March 12, 2020

    McKesson Announces Final Results of Exchange Offer

    Keywords: Corporate, Investors, Corporate

  • March 10, 2020

    McKesson Completes Split-off of Its Interest in Change Healthcare

    Keywords: Corporate, Investors, Corporate

  • March 10, 2020

    McKesson Announces Preliminary Results of Exchange Offer

    Keywords: Corporate, Investors, Corporate

  • March 05, 2020

    McKesson Sets Final Exchange Ratio of 11.4086 for Exchange Offer

    Keywords: Corporate, Investors, Corporate

  • March 03, 2020

    Health Mart Independent Pharmacies Donate Their Dispensing Services to HHS to Support “Ending the HIV Epidemic” Initiative

    Keywords: PSS-Health Mart, Health Mart, Health Mart

  • February 10, 2020

    McKesson Launches Exchange Offer to Split-Off Its Interest in Change Healthcare

    Keywords: Corporate, Corporate

  • February 04, 2020

    McKesson Reports Fiscal 2020 Third-Quarter Results

    Keywords: Corporate, Earnings, Investors, Corporate

  • January 29, 2020

    McKesson Declares Quarterly Dividend

    Keywords: Corporate, Earnings, Investors, Corporate

  • January 27, 2020

    McKesson Recognized as one of the “Best Places to Work for LGBTQ Equality” for Seventh Year in a Row

    Keywords: Corporate, Corporate

  • January 17, 2020

    AYVAKIT™ (avapritinib), FDA Approved for Treatment of PDGFRA Exon 18 Mutant GIST, Available at Biologics by McKesson

    Keywords: Corporate, Corporate

  • January 16, 2020

    McKesson Designated as 2020 Qualified Clinical Data Registry by CMS

    Keywords: Corporate, Corporate

  • January 13, 2020

    McKesson to Present at the 38th Annual J.P. Morgan Healthcare Conference: Will Provide Company Overview and Review Updated Financial Outlook

    Keywords: Corporate, Corporate

  • January 03, 2020

    McKesson Corporation to Announce Third Quarter Fiscal 2020 Results on February 4, 2020

    Keywords: Corporate, Press Release, Earnings, Investors, Corporate

  • December 18, 2019

    McKesson Reaffirms Fiscal 2020 Guidance

    Keywords: Corporate, Earnings, Investors, Corporate

  • December 12, 2019

    McKesson Selected by Department of Veterans Affairs as Prime Pharmaceutical Provider

    Keywords: Corporate, Corporate

  • December 12, 2019

    Walgreens Boots Alliance and McKesson to Create German Wholesale Joint Venture

    Keywords: Corporate, Corporate

  • December 10, 2019

    McKesson to Host Sell-Side Analyst Meeting on December 18, 2019

    Keywords: Corporate, Corporate

  • December 09, 2019

    McKesson Appoints Nancy Flores as Executive Vice President, Chief Information and Chief Technology Officer

    Keywords: Corporate, Corporate

  • December 09, 2019

    McKesson Unveils Insight into Hospital Pharmacy Trends and What Industry Can Expect in 2020

    Keywords: Corporate, Pharmacies, Healthcare Providers, Corporate

  • December 05, 2019

    US Oncology Research Announces Schedule of Presentations at the 2019 American Society of Hematology Annual Meeting and Exposition

    Keywords: US Oncology Network, Corporate, Providers, US Oncology, Healthcare Providers

  • October 30, 2019

    McKesson Reports Fiscal 2020 Second-Quarter Results

    Keywords: Corporate, Press Release, Earnings, Investors, Corporate

  • October 23, 2019

    McKesson Declares Quarterly Dividend October 23, 2019

    Keywords: Corporate, Press Release, Earnings, Investors, Corporate

  • October 21, 2019

    McKesson Hosts 2019 Onmark Summit for Community-Based Oncology Practices

    Keywords: McKesson Specialty Health and US Oncology Network, Chronic Care Management, Providers, Electronic Health Records, Disease Management, Revenue Cycle Management

  • October 21, 2019

    Distributors Reach Settlement With Ohio Counties in Opioids Case

    Keywords: McKesson Specialty Health and US Oncology Network, McKesson Medical-Surgical, Corporate, About McKesson, McKesson U.S. Pharmaceutical, Providers, Consumers, Pharmacies, Manufacturers, Investors, Healthcare Providers, McKesson Medical-Surgical, Corporate

  • October 18, 2019

    McKesson’s Board of Directors Appoints Maria Martinez as New Independent Director

    Keywords: Corporate, Press Release, Corporate

  • October 17, 2019

    McKesson Leads Investment in Community Pharmacy Ownership

    Keywords: Pharmaceutical Solutions & Services, Press Release, McKesson U.S. Pharmaceutical, Health Mart, Pharmacies

  • October 15, 2019

    McKesson and Aetion Collaborate to Advance Cancer Research with Real-World Data

    Keywords: Corporate, Corporate

  • October 08, 2019

    Fifteen Practices in The US Oncology Network Earn High-Quality Performance Ratings in the Oncology Care Model, Saving Medicare $35 Million

    Keywords: US Oncology Network, Press Release, Providers, Consumers, US Oncology, Healthcare Providers

  • October 04, 2019

    McKesson Launches Strategic Planning Solution for Community-Based Oncology Customers

    Keywords: Corporate, Corporate

  • October 03, 2019

    McKesson and Augmedix Expand Collaboration to Enhance the Doctor-Patient Relationship

    Keywords: Corporate, Press Release, Corporate

  • September 30, 2019

    McKesson Corporation to Announce Second Quarter Fiscal 2020 Results on October 30, 2019

    Keywords: Corporate, Press Release, Earnings, Investors, Corporate

  • September 25, 2019

    AMP: Access for More Patients Transforms Patient Access to Specialty Medications

    Keywords: McKesson Specialty Health and US Oncology Network, PSS-The US Oncology Network, Pharmaceutical Distribution, Manufacturers

  • September 11, 2019

    McKesson and TrakCel Launch Innovative Collaboration to Support Commercialization of Cell and Gene Therapies

    Keywords: McKesson Specialty Health and US Oncology Network, Biopharma, Pharmaceutical Distribution, Manufacturers

  • August 22, 2019

    Blue Cross and Blue Shield of Minnesota and Minnesota Oncology Announce Five-Year Collaboration

    Keywords: US Oncology Network, Providers, Consumers, US Oncology

  • August 08, 2019

    McKesson Playing Pivotal Role in Phase II of Friends of Cancer Research Real-World Evidence Initiative

    Keywords: Pharmaceutical Solutions & Services, McKesson U.S. Pharmaceutical, Providers, Electronic Health Records, Manufacturers

  • August 07, 2019

    TURALIO (pexidartinib), FDA Approved Treatment of TGCT, Available at Biologics by McKesson

    Keywords: McKesson Specialty Health and US Oncology Network, Pharmaceutical Solutions & Services, Providers, Consumers, Pharmaceutical Distribution, Manufacturers

  • August 01, 2019

    NUBEQA (darolutamide), FDA Approved for Treatment of High-Risk Non-Metastatic Prostate Cancer, Available at Biologics by McKesson

    Keywords: McKesson Specialty Health and US Oncology Network, PSS-The US Oncology Network, Press Release, Consumers, Manufacturers

  • July 31, 2019

    McKesson Reports Fiscal 2020 First-Quarter Results

    Keywords: Corporate, Earnings, Investors, Corporate

  • July 25, 2019

    McKesson Opens New Distribution Center in Seattle Area

    Keywords: Corporate, Press Release

  • July 17, 2019

    McKesson Named One of the Best Places to Work for Disability Inclusion

    Keywords: McKesson Ventures, Press Release, Consumers, Investors, Corporate

  • July 09, 2019

    Northern California Prostate Cancer Center Joins The US Oncology Network, Advancing Quality Care and Operational Efficiency

    Keywords: US Oncology Network, Providers, US Oncology

  • July 08, 2019

    XPOVIO (selinexor) Available for Order at Biologics by McKesson

    Keywords: Corporate, Corporate

  • June 27, 2019

    McKesson Issues Statement on Change Healthcare IPO

    Keywords: Corporate, Press Release, Corporate

  • June 25, 2019

    McKesson ideaShare Empowers Independent Pharmacy

    Keywords: Pharmaceutical Solutions & Services, Press Release, McKesson U.S. Pharmaceutical, Health Mart, Pharmacies

  • June 17, 2019

    McKesson’s Board of Directors Elects Dr. Ken Washington as New Independent Director

    Keywords: Corporate, Investors, Corporate

  • June 10, 2019

    Trumm Drug Named Health Mart Pharmacy of the Year

    Keywords: Pharmaceutical Solutions & Services, Press Release, McKesson U.S. Pharmaceutical, Health Mart, Pharmacies

  • May 30, 2019

    Investigators from The US Oncology Network, US Oncology Research and McKesson Present More Than 60 Research Abstracts During the 2019 American Society of Clinical Oncology Annual Meeting

    Keywords: US Oncology Network, PSS-The US Oncology Network, US Oncology

  • May 15, 2019

    Community Pharmacists Unite, Learn, Grow at McKesson ideaShare

    Keywords: Press Release, Health Mart, Health Mart, Pharmacies

  • May 08, 2019

    McKesson Reports Fiscal 2019 Fourth-Quarter and Full-Year Results

    Keywords: Corporate, Press Release, Earnings, Investors, Corporate

  • May 02, 2019

    CIO Names McKesson’s Kathy McElligott to CIO Hall of Fame

    Keywords: Corporate, Corporate

  • May 02, 2019

    McKesson Reaches Settlement with State of West Virginia on Opioid Order Monitoring and Reporting

    Keywords:

  • April 26, 2019

    McKesson Appoints Tracy Faber to Top HR Role

    Keywords: Corporate, Who We Are, Press Release, Investors, Corporate

  • April 24, 2019

    McKesson Declares Quarterly Dividend April 24, 2019

    Keywords: Corporate, Press Release, Investors, Corporate

  • April 15, 2019

    Kirk Kaminsky to Lead McKesson’s U.S.-Based Pharmaceutical Business

    Keywords: Corporate, Corporate

  • April 10, 2019

    McKesson Corporation to Hold Fiscal 2019 Fourth Quarter Conference Call and Participate in the Bank of America Merrill Lynch Health Care Conference

    Keywords: Corporate, Earnings, Investors, Corporate

  • April 02, 2019

    Progress Towards a National Prescription Safety-Alert System: the Introduction of the ALERT Act

    Keywords: Corporate

  • April 01, 2019

    Brian Tyler Becomes McKesson’s New CEO

    Keywords: Corporate, What We Stand For, Who We Are, Press Release, Investors, Corporate

  • March 28, 2019

    McKesson Recognized as one of the “Best Places to Work for LGBTQ Equality” for Sixth Year in a Row

    Keywords: Corporate, Press Release, Corporate

  • March 26, 2019

    iKnowMed Named Top-Performing Electronic Health Record by Black Book Research for Eighth Consecutive Year

    Keywords: US Oncology Network, Providers, Consumers, Healthcare Providers

  • March 26, 2019

    McKesson ideaShare Unites Independent Pharmacy

    Keywords: Press Release, Health Mart, Health Mart, Pharmacies

  • March 21, 2019

    Biologics by McKesson Expands Specialty Pharmacy Capabilities to Serve Patients With Rare and Complex Conditions

    Keywords: Providers, Consumers, Pharmaceutical Distribution, Manufacturers

  • March 05, 2019

    McKesson Collaborates With Navigating Cancer to Offer Oncologists Enhanced Software Platform for Improved Patient Management in Value-Based Care

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Electronic Health Records

  • January 31, 2019

    McKesson Reports Fiscal 2019 Third-Quarter Results

    Keywords: Press Release, Earnings, Investors, Corporate

  • January 29, 2019

    McKesson Joins World Cancer Day Efforts

    Keywords: Press Release, Providers, Consumers, Community Days, Electronic Health Records, US Oncology, Healthcare Providers, Corporate

  • January 28, 2019

    Health Mart Welcomes President Nimesh Jhaveri

    Keywords: Press Release, Health Mart, Pharmacies

  • January 23, 2019

    McKesson Designated as 2019 Qualified Clinical Data Registry by CMS

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Electronic Health Records

  • January 07, 2019

    McKesson Corporation Fiscal 2019 Third Quarter Conference Call Scheduled for January 31, 2019

    Keywords: Press Release, Earnings, Investors, Corporate

  • January 07, 2019

    McKesson and Genpact Expand Their Relationship to Support McKesson’s Finance Operating Model Optimization

    Keywords: Press Release, Corporate

  • December 07, 2018

    XOSPATA (gilteritinib) Available at Biologics by McKesson

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, Healthcare Providers

  • December 06, 2018

    Augmedix's EHR Documentation Platform Enters Innovative Pilot With Award-Winning iKnowMed Oncology EHR

    Keywords: US Oncology Network, Providers, Consumers, Electronic Health Records, US Oncology, Healthcare Providers

  • December 03, 2018

    McKesson Presents Innovative Solutions at ASHP Midyear Clinical Meeting

    Keywords: Press Release, McKesson U.S. Pharmaceutical, Pharmacies, Healthcare Providers

  • November 30, 2018

    McKesson Announces New Global Headquarters in Las Colinas, Texas

    Keywords: Press Release, Corporate

  • November 30, 2018

    US Oncology Research Announces Schedule of Presentations at the 2018 American Society of Hematology Annual Meeting and Exposition

    Keywords: US Oncology Network, Providers, Consumers, US Oncology, Healthcare Providers

  • November 29, 2018

    McKesson's 2019 Health System Pharmacy Trends

    Keywords: Press Release, McKesson U.S. Pharmaceutical, Pharmaceutical Distribution, Pharmacies, Healthcare Providers

  • November 27, 2018

    Lynx Inventory System Now Customized for Retina Specialists

    Keywords: McKesson Specialty Health and US Oncology Network, Chronic Care Management, Providers, Healthcare Providers

  • November 02, 2018

    PANTHERx Specialty Pharmacy and RxCrossroads by McKesson Collaborate to Streamline the Channel for Precision Medicine Therapies

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Disease Management, Pharmaceutical Distribution, Manufacturers, Healthcare Providers

  • November 01, 2018

    John Hammergren Announces Retirement; Brian Tyler to Become McKesson’s CEO and Edward Mueller to Chair Board

    Keywords: Press Release, Investors, Corporate

  • October 25, 2018

    McKesson Reports Fiscal 2019 Second-Quarter Results

    Keywords: Press Release, Earnings, Investors, Corporate

  • October 23, 2018

    RxBenefit Clarity Delivers Prescription Price Transparency to Providers on athenahealth’s Cloud-based EHR

    Keywords: RelayHealth Pharmacy Solutions, Providers, Electronic Health Records, Pharmacies

  • October 22, 2018

    McKesson Relaunches Life Sciences Business to Meet Changing Industry Needs

    Keywords: McKesson Specialty Health and US Oncology Network, Electronic Health Records, Electronic Prescribing, Pharmaceutical Distribution, Manufacturers, Investors, Healthcare Providers

  • October 19, 2018

    RelayHealth Pharmacy Solutions Strengthens Retail Pharmacies’ Efforts to Expand Clinical Services with Medical Billing Platform in Collaboration with STRAND Clinical Technologies

    Keywords: RelayHealth Pharmacy Solutions, Pharmacies

  • October 11, 2018

    McKesson Prepared to Help Customers, Employees and Communities in the Wake of Hurricane Michael

    Keywords: Corporate

  • October 08, 2018

    Impactful New Science and Advancements in Cancer Care Research Revealed and Discussed at the US Oncology Research 17th Annual Science Forum

    Keywords: US Oncology Network, US Oncology

  • October 04, 2018

    McKesson Corporation Fiscal 2019 Second Quarter Conference Call Scheduled for October 25, 2018

    Keywords: Earnings, Investors, Corporate

  • October 04, 2018

    The US Oncology Network Announces Top-Tier MIPS Results

    Keywords: US Oncology Network, US Oncology

  • October 04, 2018

    McKesson Sponsors Community Pharmacy Ownership Workshop

    Keywords: Pharmacies, Corporate

  • October 01, 2018

    Beyond the prescription: McKesson celebrates heroes in white coats

    Keywords: McKesson U.S. Pharmaceutical, Pharmaceutical Distribution, Pharmacies

  • September 26, 2018

    COPIKTRA (duvelisib) Available for Order at Biologics, Inc.

    Keywords: McKesson Specialty Health and US Oncology Network, Disease Management, Healthcare Providers

  • September 26, 2018

    McKesson Announces Renowned Leadership for Opioid-Focused Foundation

    Keywords: Press Release, Corporate

  • September 25, 2018

    McKesson National Survey Reveals Most Americans Are Optimistic About New Technologies in Healthcare, yet Worry About Cancer Cost

    Keywords: Press Release, Providers, Consumers, Disease Management, US Oncology, Healthcare Providers, Corporate

  • September 25, 2018

    McKesson Medical-Surgical and ILÚM Health Solutions Announce Distribution Alliance in Community Hospital Market

    Keywords: Press Release, Providers, Disease Management, Patient Safety, Investors, Healthcare Providers, McKesson Medical-Surgical

  • September 13, 2018

    McKesson Board of Directors Elects Dominic Caruso as New Independent Director

    Keywords: Corporate

  • September 12, 2018

    Health Mart Launches National ‘Power Your Partnerships’ Series

    Keywords: Press Release, Health Mart, Health Mart, Pharmacies

  • August 23, 2018

    McKesson Corporation to Present at the Morgan Stanley Global Healthcare Conference

    Keywords: Corporate

  • August 23, 2018

    US Oncology Research Joins Agendia’s FLEX Big Data Initiative, Accelerating Diagnostic Discoveries in Breast Cancer and Enabling Precision Oncology

    Keywords: US Oncology Network, Providers, US Oncology

  • August 15, 2018

    Novocure and US Oncology Research Announce Collaboration on PANOVA-3 Trial for Patients with Advanced Pancreatic Cancer

    Keywords: US Oncology Network, Providers, US Oncology

  • August 06, 2018

    Progressive Care Integrates with Illinois Cancer Specialists to Join The US Oncology Network

    Keywords: US Oncology Network, Providers, US Oncology

  • July 31, 2018

    McKesson Appoints Brian Tyler as President and Chief Operating Officer

    Keywords: Corporate

  • July 26, 2018

    McKesson Reports Fiscal 2019 First-Quarter Results

    Keywords: Press Release, Earnings, Investors, Corporate

  • July 23, 2018

    TIBSOVO (ivosidenib), an IDH1 Inhibitor Approved for Treatment of Relapsed/Refractory Acute Myeloid Leukemia with an IDH1 Mutation, Available for Order at Biologics, Inc.

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Pharmaceutical Distribution

  • July 17, 2018

    The US Oncology Network Promotes Leader in Value-Based Care Dr. Marcus Neubauer to Chief Medical Officer

    Keywords: US Oncology Network, Press Release, Consumers, US Oncology

  • July 09, 2018

    Power of Community Pharmacies Showcased at McKesson ideaShare

    Keywords: Health Mart, Health Mart, Pharmacies

  • July 09, 2018

    The US Oncology Network Welcomes Breast Surgeon Dr. Loren Rourke to a New Role as Chief Surgical Officer

    Keywords: US Oncology Network, Providers, US Oncology

  • July 05, 2018

    McKesson Corporation Fiscal 2019 First Quarter Conference Call Scheduled for July 26, 2018

    Keywords: Press Release, Earnings, Investors, Corporate

  • June 29, 2018

    Combination Therapy BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) for the Treatment of BRAF-mutant Melanoma, Available for Order at Biologics, Inc.

    Keywords: Pharmacies, Corporate

  • June 29, 2018

    Bartle’s Pharmacy Receives McKesson’s Pharmacy of the Year Award

    Keywords: Press Release, Health Mart, Health Mart, Pharmacies

  • June 29, 2018

    McKesson Debuts Drug Spend Savings Technology at HFMA

    Keywords: Corporate

  • June 28, 2018

    McKesson Reaffirms Fiscal 2019 Guidance and Provides Preliminary Guidance for the First Quarter

    Keywords: Earnings, Corporate

  • June 26, 2018

    McKesson Ventures Donates $10,000 to Meals on Wheels America on Behalf of Landmark Health

    Keywords: McKesson Ventures

  • June 01, 2018

    McKesson Completes Acquisition of Medical Specialties Distributors

    Keywords: Corporate

  • May 30, 2018

    Oncologists from The US Oncology Network and US Oncology Research to Present Data from More Than 40 Abstracts During the 54th Annual ASCO Meeting

    Keywords: US Oncology Network, US Oncology

  • May 29, 2018

    McKesson Corporation to Present at the Goldman Sachs 39th Annual Global Healthcare Conference and Host Investor Day

    Keywords: Corporate

  • May 29, 2018

    TAVALISSE (fostamatinib disodium hexahydrate) Approved by FDA, Available for Order at Biologics, Inc.

    Keywords: McKesson Specialty Health and US Oncology Network, Pharmacies

  • May 24, 2018

    McKesson Reports Fiscal 2018 Fourth-Quarter and Full-Year Results

    Keywords: Press Release, Earnings, Investors, Corporate

  • May 16, 2018

    Real-World Evidence from McKesson Supports First-Ever FDA Approval for Metastatic Merkel Cell Carcinoma Drug

    Keywords: US Oncology Network, Press Release, Electronic Health Records, US Oncology, Manufacturers

  • May 07, 2018

    McKesson ideaShare: The Independent’s Power to Perform

    Keywords: Press Release, McKesson U.S. Pharmaceutical, Pharmacies

  • May 07, 2018

    Texas Oncology Receives 2018 PBMI Excellence Award for Care Management Strategies

    Keywords: US Oncology Network

  • April 30, 2018

    McKesson Board of Directors Elects Brad Lerman as New Independent Director

    Keywords: Press Release, Corporate

  • April 30, 2018

    McKesson Corporation Fiscal 2018 Fourth Quarter Conference Call Scheduled for May 24, 2018

    Keywords: Press Release, Investors, Corporate

  • April 25, 2018

    McKesson Launches Multi-Year Strategic Growth Initiative; Reaffirms Fiscal 2018 Outlook and Provides Preliminary Fiscal 2019 Outlook

    Keywords: Press Release, Earnings, Investors, Corporate

  • April 20, 2018

    McKesson Board of Directors Releases Findings and Recommendations of Independent Investigation

    Keywords: Press Release, Corporate

  • April 05, 2018

    McKesson Launches Health Mart Atlas

    Keywords: Corporate

  • April 05, 2018

    McKesson Specialty Health Partners with CoverMyMeds to Deliver Keynote Address at eyeforpharma Philadelphia 2018

    Keywords: McKesson Specialty Health and US Oncology Network, Pharmaceutical Distribution, Manufacturers

  • April 04, 2018

    McKesson Specialty Health and CoverMyMeds Launch ExpressCoverage, an Integrated eServices Platform Designed to Improve the Patient Care Journey

    Keywords: McKesson Specialty Health and US Oncology Network, Pharmaceutical Distribution, Manufacturers

  • March 29, 2018

    McKesson Announces New Initiatives, Launches Foundation to Help Fight Nation’s Opioid Epidemic

    Keywords: Press Release, Investors, Corporate

  • March 12, 2018

    Virginia Cancer Specialists and The US Oncology Network Welcome Breast Surgeon Dr. Hernan Vargas

    Keywords: US Oncology Network, Press Release, Providers, US Oncology

  • March 01, 2018

    RelayHealth Pharmacy Solutions and CoverMyMeds Implement Industry's Most Accurate Real-Time Prescription Benefit Solution

    Keywords: RelayHealth Pharmacy Solutions, Providers

  • February 27, 2018

    James Drug Store Wins Team of the Year Award at Pharmacy Development Services Super-Conference

    Keywords: Press Release, Health Mart, Health Mart, Pharmacies

  • February 26, 2018

    McKesson Specialty Health and Cryoport Collaborate to Bolster Logistics Services to Support Commercialization of Cell and Gene Therapies

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Pharmaceutical Distribution, Manufacturers

  • February 22, 2018

    McKesson Corporation Announces Pricing of Tender Offer

    Keywords: Press Release, Earnings, Investors, Corporate

  • February 22, 2018

    McKesson Corporation Announces Early Tender Results

    Keywords: Press Release, Investors, Corporate

  • February 22, 2018

    iKnowMed Ranked Number One Oncology Electronic Health Record by Black Book Research for Seventh Consecutive Year

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Electronic Health Records

  • February 21, 2018

    ERLEADA (apalutamide), the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer, available for order at Biologics, Inc.

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Consumers, Pharmaceutical Distribution, Manufacturers

  • February 07, 2018

    McKesson Pharmacy Systems and Creative Pharmacist Collaborate to Enhance Clinical Programs for Community Pharmacy

    Keywords: Press Release, Pharmacies, McKesson Pharmacy Systems

  • February 01, 2018

    McKesson Reports Fiscal 2018 Third-Quarter Results

    Keywords: Earnings, Corporate

  • January 26, 2018

    McKesson Specialty Health Designated as 2018 Qualified Clinical Data Registry by CMS

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Electronic Health Records

  • January 25, 2018

    Biologics, Inc. Joins Medimpact Direct Specialty Program’s Specialty Pharmacy Network

    Keywords: McKesson Specialty Health and US Oncology Network, Pharmaceutical Distribution, Manufacturers

  • January 18, 2018

    Consultants in Medical Oncology and Hematology Joins The US Oncology Network, Enhancing Its Ability to Deliver High-Quality Care throughout the Greater Philadelphia Area

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Consumers, US Oncology

  • January 16, 2018

    McKesson Ventures Donates $10,000 to Alzheimer’s Association

    Keywords: McKesson Ventures, Corporate

  • January 05, 2018

    iKnowMed EHR and iKnowMed Generation 2 EHR Receive 2015 ONC-ACB Certification

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Electronic Health Records

  • January 04, 2018

    McKesson Corporation Fiscal 2018 Third Quarter Conference Call Scheduled for February 1, 2018

    Keywords: Press Release, Investors, Corporate

  • January 03, 2018

    McKesson Completes Acquisition of RxCrossroads

    Keywords: Press Release, Corporate

  • December 21, 2017

    BenchmarkPortal Certifies McKesson Specialty Health’s Third Party Logistics Service Center as Center of Excellence

    Keywords: McKesson Specialty Health and US Oncology Network, Pharmaceutical Distribution, Manufacturers

  • December 19, 2017

    McKesson Corporation to Present at the 36th Annual J.P. Morgan Healthcare Conference

    Keywords: Press Release, Corporate

  • December 18, 2017

    McKesson Announces Departure of James Beer, EVP and CFO; Appoints Internal Successor, Britt Vitalone; Reaffirms Fiscal 2018 Outlook

    Keywords: Press Release, Corporate

  • December 04, 2017

    McKesson Specialty Health and US Oncology Research Announce Schedule of Presentations at the 2017 American Society of Hematology Annual Meeting and Exposition

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, US Oncology

  • December 04, 2017

    McKesson RxO Team Identifies Five Health System Pharmacy Trends to Watch in 2018

    Keywords: Press Release, McKesson U.S. Pharmaceutical

  • December 01, 2017

    McKesson to Showcase Clinical Expertise and Technology Solutions at ASHP Midyear Clinical Meeting 2017

    Keywords: McKesson U.S. Pharmaceutical, Pharmacies

  • November 28, 2017

    Virginia Cancer Specialists and The US Oncology Network Welcome Dr. Stephanie Akbari

    Keywords: US Oncology Network, Press Release, US Oncology, Healthcare Providers

  • November 09, 2017

    Human Rights Campaign Honors McKesson as a Best Place to Work for Fifth Consecutive Year

    Keywords: Corporate

  • November 06, 2017

    McKesson Strengthens Its Portfolio of Manufacturer Solutions With the Acquisition of RxCrossroads

    Keywords: Pharmaceutical Distribution, Investors, Corporate

  • November 03, 2017

    Frederick Oncology & Hematology Associates Joins Maryland Oncology Hematology and The US Oncology Network

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, US Oncology

  • November 02, 2017

    US Oncology Research Annual Science Forum Focuses on Advances in Clinical Research, Enabling Promising New Treatments for Patients in the Community Setting

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology

  • November 01, 2017

    CALQUENCE® (acalabrutinib) Approved for Previously-Treated Mantle Cell Lymphoma, Available for Order at Biologics, Inc.

    Keywords: McKesson Specialty Health and US Oncology Network, Pharmaceutical Distribution, Manufacturers

  • October 31, 2017

    McKesson Recommends Quick Federal Action on Key Opioid Solution Ideas

    Keywords: Providers, Pharmaceutical Distribution, Pharmacies, Manufacturers, Healthcare Providers, Corporate

  • October 30, 2017

    McKesson Signs Agreement with NRG to Install Solar Arrays at McKesson Facility

    Keywords: Corporate

  • October 26, 2017

    McKesson Reports Fiscal 2018 Second-Quarter Results

    Keywords: Press Release, Earnings, Investors, Corporate

  • October 23, 2017

    Health Mart and APCI Celebrate Pharmacists on Florida Independent Pharmacy Day

    Keywords: McKesson U.S. Pharmaceutical

  • October 23, 2017

    McKesson Supports Declaring Opioid Epidemic a National Emergency

    Keywords: Press Release, Corporate

  • October 17, 2017

    McKesson Corporation to Present at the 26th Annual Credit Suisse Healthcare Conference

    Keywords: Corporate

  • October 17, 2017

    McKesson Partners with Lyft to Support California Wildfire Victims

    Keywords: Press Release, Corporate

  • October 17, 2017

    Health Mart Showcases Solutions for Clinical and Financial Performance at NCPA

    Keywords: Health Mart, Health Mart, Pharmacies

  • October 16, 2017

    McKesson RxOwnership Expands Support of Independent Pharmacy Ownership

    Keywords: McKesson U.S. Pharmaceutical, Pharmacies

  • October 13, 2017

    McKesson Commits $100,000 to the American Red Cross to Support California Wildfire Victims

    Keywords: Corporate

  • October 11, 2017

    VERZENIO (abemaciclib) Approved for Treatment of Metastatic Breast Cancer, Available for Order at Biologics, Inc.

    Keywords: McKesson Specialty Health and US Oncology Network, Manufacturers

  • October 05, 2017

    McKesson Corporation Fiscal 2018 Second Quarter Conference Call Scheduled for October 26, 2017

    Keywords: Press Release, Earnings, Investors, Corporate

  • October 02, 2017

    Employee Volunteers Create 15,000 Care Packages for Cancer Patients

    Keywords: Corporate Citizenship, Consumers, Community Days, Corporate

  • September 27, 2017

    McKesson Ventures Expands Investment Team

    Keywords: McKesson Ventures, Press Release, Corporate

  • September 25, 2017

    Health Mart Kicks-Off New ‘Revenue Remedies’ Town Hall Series

    Keywords: Health Mart, Health Mart, Pharmacies

  • September 19, 2017

    Southern Cancer Center is Global Leader in Kidney Cancer Clinical Trial

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology

  • September 14, 2017

    McKesson Increases Hurricane Relief Commitment to $600,000

    Keywords:

  • September 12, 2017

    US Oncology Research Plays an Important Role in the Clinical Development for NERLYNX™ (Neratinib) Tablets

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology, Pharmaceutical Distribution, Manufacturers

  • September 08, 2017

    Hurricane Irma: McKesson Prepares to Support Healthcare Providers, Pharmacies and First Responders

    Keywords: Corporate

  • August 31, 2017

    McKesson Commits More than $300,000 in Relief Support for Hurricane Harvey

    Keywords: Corporate Citizenship, Press Release, Consumers, Investors, Corporate

  • August 22, 2017

    McKesson Corporation to Present at the Morgan Stanley Global Healthcare Conference

    Keywords: Press Release, Investors, Corporate

  • August 22, 2017

    BESPONSA (inotuzumab ozogamicin) Approved for Treatment of Adult Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia, available for order at Biologics, Inc.

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, Pharmaceutical Distribution, Manufacturers

  • August 03, 2017

    Allscripts to Acquire McKesson’s Enterprise Information Solutions Business

    Keywords: Press Release, Providers, Electronic Health Records, Investors, Corporate

  • August 01, 2017

    US Oncology Research and Epizyme Establish Collaboration to Identify Non-Hodgkin Lymphoma Patients with EZH2 Mutations

    Keywords: US Oncology Network, Providers, US Oncology

  • July 28, 2017

    McKesson Announces Final Voting Results from 2017 Annual Meeting of Stockholders

    Keywords: Investors, Corporate

  • July 27, 2017

    McKesson Reports Fiscal 2018 First-Quarter Results

    Keywords: Earnings, Investors, Corporate

  • July 26, 2017

    McKesson Declares Quarterly Dividend July 26, 2017

    Keywords: Earnings, Investors, Corporate

  • July 26, 2017

    McKesson Announces Preliminary Voting Results from 2017 Annual Meeting of Stockholders

    Keywords: Investors, Corporate

  • July 21, 2017

    NERLYNX (neratinib) Tablets Approved for HER2+ Breast Cancer in the Extended Adjuvant Setting

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, Pharmaceutical Distribution, Manufacturers

  • July 13, 2017

    McKesson ideaShare: Shaping the Independent’s Power to Drive Performance and Profitability

    Keywords: Press Release, McKesson U.S. Pharmaceutical, Pharmaceutical Distribution, Pharmacies

  • July 12, 2017

    McKesson Corporation Fiscal 2018 First Quarter Conference Call Scheduled for July 27, 2017

    Keywords: Earnings, Investors, Corporate

  • July 10, 2017

    McKesson Pharmacy Systems Unveils Key Enhancements for Its Pharmacy Management Product Lines

    Keywords: Pharmacies, McKesson Pharmacy Systems

  • July 06, 2017

    Mac Prescription Shop Health Mart Receives McKesson’s 2017 Pharmacy of the Year Award

    Keywords: Press Release, Health Mart, Health Mart, Pharmacies

  • July 05, 2017

    McKesson Specialty Health Completes Acquisition of intraFUSION

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, M&A

  • June 29, 2017

    Biologics, Inc. Earns Prestigious URAC Accreditation for Specialty Pharmacy

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Consumers, Pharmaceutical Distribution, Pharmacies, Manufacturers, Investors, Healthcare Providers

  • June 28, 2017

    McKesson Reaffirms Fiscal 2018 Guidance

    Keywords: Earnings, Investors, Corporate

  • June 23, 2017

    The US Oncology Network Hosts Second Annual Boot Camp Focusing on New Value-Based Care and Payment Models

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, US Oncology

  • June 22, 2017

    McKesson Specialty Health Expands Provider Offerings with Acquisition of intraFUSION

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, M&A

  • June 21, 2017

    McKesson Corporation to Webcast Investor Day

    Keywords: Investors, Corporate

  • June 14, 2017

    McKesson Specialty Health and The US Oncology Network Expand Agreement with The National Comprehensive Cancer Network, Adding New Disease States to Value Pathways

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, US Oncology

  • June 13, 2017

    Arizona Oncology Opens State-of-the-Art Cancer Treatment Center at ASU Research Park

    Keywords: US Oncology Network, Providers, Consumers, US Oncology

  • June 08, 2017

    Virginia Cancer Specialists Opens New Research Facility for Phase I Clinical Trials, Leading the Region in Advanced Cancer Research

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology

  • June 01, 2017

    McKesson Specialty Health Approved as Qualified Clinical Data Registry by CMS

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Electronic Health Records

  • May 31, 2017

    Community Oncologists from The US Oncology Network and US Oncology Research Share Meaningful Research and Visionary Thinking During American Society of Clinical Oncology Annual Meeting

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology

  • May 25, 2017

    McKesson Corporation to Present at the Goldman Sachs 38th Annual Global Healthcare Conference

    Keywords: Corporate

  • May 24, 2017

    McKesson Declares Quarterly Dividend May 24, 2017

    Keywords: Earnings, Investors, Corporate

  • May 24, 2017

    Biologics’ Patient Access Services Team Procures more than $44 Million in Co-pay Assistance for Cancer Patients in 2016

    Keywords: McKesson Specialty Health and US Oncology Network, Consumers, Pharmaceutical Distribution, Pharmacies

  • May 22, 2017

    IMFINZI (durvalumab) Approved for Previously Treated Patients with Advanced Bladder Cancer, available immediately at Biologics, Inc.

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, Pharmaceutical Distribution, Pharmacies, Manufacturers

  • May 18, 2017

    McKesson Reports Fiscal 2017 Fourth-Quarter and Full-Year Results

    Keywords: Earnings, Investors, Corporate

  • May 12, 2017

    McKesson Specialty Health Selected by TESARO to provide ZEJULA (niraparib), Approved for the Treatment of Recurrent Ovarian Cancer

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Consumers, US Oncology, Pharmaceutical Distribution, Pharmacies, Manufacturers

  • May 11, 2017

    ALUNBRIG (brigatinib) Approved for the Treatment of ALK+ Metastatic Non-Small Cell Lung Cancer, Available for Order at Biologics, Inc.

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Consumers, Pharmaceutical Distribution, Manufacturers

  • May 03, 2017

    RYDAPT (midostaurin) Approved for the Treatment of FLT3-Mutated Acute Myeloid Leukemia, available for order at Biologics, Inc.

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Consumers, Pharmaceutical Distribution, Manufacturers

  • April 27, 2017

    Thought Leaders from McKesson Specialty Health and The US Oncology Network Are Key Presenters at the 2017 Community Oncology Conference

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, US Oncology

  • April 25, 2017

    US Oncology Research Enrolls 2,900 Patients in Leading-Edge Clinical Trials in Twelve Months

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Consumers, US Oncology

  • April 24, 2017

    Biologics, Inc. Selected by TESARO as a Specialty Pharmacy Provider for ZEJULA (niraparib), Approved for the Treatment of Recurrent Ovarian Cancer

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Pharmaceutical Distribution

  • April 20, 2017

    McKesson Corporation Fiscal 2017 Fourth Quarter Conference Call Scheduled for May 18, 2017

    Keywords: Press Release, Earnings, Investors, Corporate

  • April 20, 2017

    McKesson Response to Arkansas Department of Correction’s Planned Executions

    Keywords: Press Release, Corporate

  • April 11, 2017

    McKesson Presents New Approaches to Patient-Centric Behavioral Coaching at CBI Conference

    Keywords: McKesson Specialty Health and US Oncology Network, Pharmaceutical Distribution, Manufacturers

  • April 03, 2017

    McKesson Completes Acquisition of CoverMyMeds

    Keywords: Pharmaceutical Distribution, Pharmacies, Corporate

  • March 30, 2017

    McKesson ideaShare: Shaping the Independent’s Power to Perform

    Keywords: Press Release

  • March 29, 2017

    BAVENCIO (avelumab) Approved for the Treatment of Metastatic Merkel Cell Carcinoma, Available for Order at Biologics, Inc.

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Pharmaceutical Distribution

  • March 17, 2017

    KISQALI (ribociclib) Approved for the Treatment of HR+/HER2- Advanced Breast Cancer, available for order at Biologics, Inc.

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Pharmaceutical Distribution

  • March 02, 2017

    McKesson and Change Healthcare Complete the Creation of New Healthcare Information Technology Company

    Keywords: Corporate

  • March 02, 2017

    McKesson Provides Financial Update to Reflect Creation of a New Healthcare Information Technology Company

    Keywords: Earnings, Corporate

  • March 01, 2017

    Medical Oncology Hematology Consultants Joins The US Oncology Network

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, US Oncology

  • March 01, 2017

    XERMELO (telotristat ethyl) Approved for the Treatment of Carcinoid Syndrome, Available for Order Immediately at Biologics, Inc.

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Pharmaceutical Distribution

  • February 28, 2017

    Black Book Research Recognizes iKnowMed as the Number One Ranked Oncology Electronic Health Record for Sixth Consecutive Year

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Electronic Health Records

  • February 02, 2017

    McKesson Specialty Health and The US Oncology Network to Showcase Value-Based Care Expertise During Cancer Center Business Summit

    Keywords: McKesson Specialty Health and US Oncology Network, Providers

  • February 01, 2017

    Southern Cancer Center Joins The US Oncology Network

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, US Oncology

  • January 25, 2017

    McKesson Reports Fiscal 2017 Third-Quarter Results

    Keywords: Earnings, Investors, Corporate

  • January 25, 2017

    McKesson Declares Quarterly Dividend January 25, 2017

    Keywords: Earnings, Investors, Corporate

  • January 17, 2017

    McKesson Finalizes Settlement with U.S. Department of Justice and U.S. Drug Enforcement Administration to Resolve Past Claims

    Keywords: Press Release, Corporate

  • January 11, 2017

    McKesson Specialty Health and The US Oncology Network Invited to Participate in the Final White House “Making Health Care Better” Series Focused on Community Oncology

    Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology

  • January 05, 2017

    McKesson and Change Healthcare Announce New Company Will Be Named Change Healthcare

    Keywords: Press Release

  • January 04, 2017

    McKesson Corporation Fiscal 2017 Third Quarter Conference Call Scheduled for January 25, 2017

    Keywords: Press Release

  • December 28, 2016

    McKesson Completes Acquisition of Rexall Health and Appoints Domenic Pilla as CEO of McKesson Canada

    Keywords: Press Release, Corporate

  • December 20, 2016

    McKesson Corporation to Present at 35th Annual J.P. Morgan Healthcare Conference

    Keywords: Press Release, Investors, Corporate

  • December 20, 2016

    RUBRACA (rucaparib) Approved for the Treatment of Advanced Ovarian Cancer, Available Immediately at Biologics, Inc.

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Consumers, Pharmaceutical Distribution, Manufacturers

  • December 14, 2016

    McKesson Receives Regulatory Approval for Rexall Health Acquisition

    Keywords: Press Release, Pharmaceutical Distribution, Pharmacies, Corporate

  • December 13, 2016

    McKesson Specialty Health Expands Operations with New Office in Downtown Evansville, Indiana

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Consumers, Revenue Cycle Management

  • December 08, 2016

    US Oncology Research Annual Science Forum Focuses on Delivering the Latest Research Opportunities to Patients in the Community Setting

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Consumers, US Oncology

  • December 05, 2016

    Human Rights Campaign Honors McKesson Corporation as Best Place to Work for LGBT Employees for Fourth Year in a Row

    Keywords: Press Release

  • December 05, 2016

    McKesson Pharmacy Optimization® Team Identifies Five Health System Pharmacy Trends to Watch in 2017

    Keywords: Press Release, McKesson U.S. Pharmaceutical, Pharmaceutical Distribution, Nurses

  • December 02, 2016

    McKesson Introduces Central Fill as a Service™

    Keywords: Chronic Care Management, Press Release, McKesson U.S. Pharmaceutical, Disease Management, Pharmaceutical Distribution, Pharmacies, McKesson Pharmacy Systems

  • December 02, 2016

    McKesson to Spotlight Solutions at ASHP Midyear Clinical Meeting 2016

    Keywords: McKesson Ventures, Press Release, McKesson U.S. Pharmaceutical, Pharmacies

  • December 01, 2016

    Blood & Cancer Center Joins Florida Cancer Affiliates

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, US Oncology

  • November 30, 2016

    US Oncology Research Announces Schedule of Presentations at the 2016 American Society of Hematology Annual Meeting and Exposition

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, US Oncology

  • November 15, 2016

    Rocky Mountain Cancer Centers First In Region to Offer Newly Approved Gallium DOTATATE PET/CT for Neuroendocrine Tumors

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Consumers, US Oncology

  • November 14, 2016

    McKesson Pharmacy Systems Unveils EnterpriseRx® 7.0

    Keywords: Press Release, Patient Safety, Pharmacies, Healthcare Providers, McKesson Pharmacy Systems

  • November 10, 2016

    McKesson Specialty Health Launches Its Successful In-Office Dispensing Solution to Rheumatology and Gastroenterology Providers

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Pharmaceutical Distribution

  • November 07, 2016

    McKesson Specialty Health Hosts 2016 Onmark Fall Leadership Summit For Community-Based Oncology Practices

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers

  • November 03, 2016

    BenchmarkPortal Certifies McKesson Specialty Health’s Reimbursement, Access & Safety Services Solution Center as Center of Excellence

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Consumers, Patient Safety, Manufacturers

  • November 02, 2016

    Lancet Oncology Multi-Part Study on Oncology Drug Safety in the 21st Century Reveals the Need for New Approaches to Biosimilar and Generic Oncology Drugs

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Consumers, US Oncology, Manufacturers

  • November 01, 2016

    OHC Joins The US Oncology Network, Gaining Resources to Advance Quality Care and Operational Efficiency

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Consumers, US Oncology

  • October 27, 2016

    McKesson Reports Fiscal 2017 Second-Quarter Results and Revised Fiscal 2017 Outlook

    Keywords: Press Release, Earnings, Investors, Corporate

  • October 27, 2016

    McKesson Declares Quarterly Dividend October 27, 2016

    Keywords: Press Release, Earnings, Investors, Corporate

  • October 26, 2016

    Varian and McKesson Specialty Health Announce Strategic Agreement for Advanced Radiotherapy Equipment and Software

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Electronic Health Records, US Oncology

  • October 24, 2016

    McKesson Releases Fiscal 2016 Corporate Social Responsibility Report

    Keywords: Corporate Citizenship, Who We Are, Press Release, Consumers, Investors, Corporate

  • October 20, 2016

    McKesson Corporation to Present at the 25th Annual Credit Suisse Healthcare Conference

    Keywords: Press Release, Corporate

  • October 18, 2016

    Health Mart Showcases New Tools to Drive Better Patient Outcomes and Business Growth at NCPA

    Keywords: Press Release, Health Mart, Health Mart, Pharmacies

  • October 18, 2016

    Compass Oncology Breaks Ground on Multi-Disciplinary Cancer Center

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, US Oncology

  • October 06, 2016

    McKesson Corporation Fiscal 2017 Second Quarter Conference Call Scheduled for October 27, 2016

    Keywords: Press Release, Earnings, Investors, Corporate

  • October 05, 2016

    McKesson RxOwnership Supports Future of Independent Pharmacy Ownership at NCPA Annual Convention

    Keywords: Press Release, McKesson U.S. Pharmaceutical, Pharmacies

  • October 05, 2016

    CABOMETYXTM (cabozantinib) Tablets Approved for Advanced Renal Cell Carcinoma, available at Biologics, Inc.

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Consumers, Pharmaceutical Distribution, Manufacturers

  • October 04, 2016

    The US Oncology Network Selects Myriad Genetics as Preferred Provider for Hereditary Cancer Testing

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Consumers, US Oncology

  • September 30, 2016

    McKesson Salutes Important Role Pharmacists Play in Improving Patient Health During American Pharmacists Month

    Keywords: Press Release, Health Mart, Providers, Consumers, Health Mart, Pharmacies

  • September 29, 2016

    Clear Value Plus Reaches Milestone 100,000th Clinical Decision Recorded

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Electronic Health Records

  • September 26, 2016

    Health Mart® Kicks-Off New Town Hall Series: Resolve to Evolve to Help Pharmacies Improve their Clinical, Financial, and Operational Performance for Profitability

    Keywords: Press Release, Health Mart, Consumers, Health Mart, Pharmacies, Healthcare Providers

  • September 23, 2016

    McKesson Pharmacy Systems Launches Pharmaserv 7.5

    Keywords: Chronic Care Management, Press Release, Disease Management, Patient Safety, Pharmacies, McKesson Pharmacy Systems

  • September 22, 2016

    Arizona Oncology Implements Advanced Cervical Imaging Technology to Assist With the Early Detection of Cervical Cancer

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Consumers, US Oncology

  • September 20, 2016

    18,000 McKesson Employees Gather to Raise Awareness, Give Back to Cancer Patients in Need

    Keywords: Press Release, Community Days, Corporate

  • September 15, 2016

    Health Mart® Ranks Highest in Customer Satisfaction in J.D. Power 2016 U.S. Pharmacy Study

    Keywords: Press Release, Health Mart, Health Mart, Pharmacies

  • September 14, 2016

    McKesson a Finalist for PM360 Trailblazer Awards 2016

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, McKesson U.S. Pharmaceutical, Consumers, Patient Safety, Manufacturers

  • September 12, 2016

    Arizona Oncology Adds Four Gynecologic Oncologists, Expanding World-Class Gynecologic Cancer Services Throughout the Region

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Consumers, US Oncology

  • September 06, 2016

    Woodlands Medical Specialists Joins The US Oncology Network

    Keywords: US Oncology Network, Press Release, Providers, US Oncology

  • August 25, 2016

    New Study Shows Lumpectomy With Radiation Therapy to Treat Breast Cancer in a Community Setting Results in Higher Than Average Patient Survival Rates

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release

  • August 23, 2016

    McKesson Corporation to Present at Morgan Stanley Global Healthcare Conference

    Keywords: Press Release, Investors, Corporate

  • August 09, 2016

    Missouri Cancer Associates Adds New Physician, Enhancing Access to Quality Care

    Keywords: US Oncology Network, Press Release

  • July 27, 2016

    McKesson Reports Fiscal 2017 First-Quarter Results

    Keywords: Press Release, Earnings, Investors, Corporate

  • July 26, 2016

    McKesson Declares Quarterly Dividend July 26, 2016

    Keywords: Press Release, Investors, Corporate

  • July 22, 2016

    Arizona Oncology Breaks Ground for State-of-the-art Treatment Center in the East Valley

    Keywords: US Oncology Network, Press Release, Providers, US Oncology

  • July 21, 2016

    SpaceOAR hydrogel is Now Available for Prostate Cancer Patients Being Treated at Arizona Oncology

    Keywords: US Oncology Network, Press Release, Providers, US Oncology

  • July 14, 2016

    Virginia Cancer Specialists First in the World to Enroll Patient in Cutting-Edge Lung Cancer Clinical Trial

    Keywords: US Oncology Network, Press Release, Providers, US Oncology

  • July 12, 2016

    Virginia Cancer Specialists Receives Clinical Trials Research Award from Conquer Cancer Foundation

    Keywords: US Oncology Network, Press Release, Providers, US Oncology

  • July 07, 2016

    McKesson Corporation Fiscal 2017 First Quarter Conference Call Scheduled for July 27, 2016

    Keywords: Press Release, Earnings, Investors, Corporate

  • July 05, 2016

    Anthem Blue Cross of California and Valley Radiotherapy Associates Implement New Rates for Breast Cancer Patients

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers

  • June 30, 2016

    The US Oncology Network Announces Affiliated Practices Chosen To Participate In Oncology Care Model (OCM)

    Keywords: US Oncology Network, Press Release, US Oncology

  • June 29, 2016

    McKesson Updates Fiscal 2017 Guidance

    Keywords: Press Release, Earnings, Corporate

  • June 28, 2016

    McKesson to Explore Strategic Alternatives for Enterprise Information Solutions

    Keywords: Press Release, Corporate

  • June 27, 2016

    Rex Pharmacy, a Health Mart Pharmacy, Receives McKesson’s 2016 Pharmacy of the Year Award

    Keywords: Press Release, Health Mart, Providers, Consumers, Health Mart, Pharmacies, Nurses, Manufacturers, Investors, Healthcare Providers

  • June 27, 2016

    McKesson Shares Ideas with Independent Pharmacies to Deliver Better Patient Outcomes and Grow Their Businesses

    Keywords: Press Release, Providers, Consumers, Health Mart, Pharmacies, Nurses, Manufacturers, Investors, Healthcare Providers, Corporate

  • June 22, 2016

    McKesson Corporation to Webcast Investor Day

    Keywords: Press Release, Corporate

  • June 20, 2016

    McKesson Specialty Health Launches Optimization Toolkit for Oncology In-Office Dispensing Program

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers

  • June 08, 2016

    The US Oncology Network Holds Intensive Boot Camp to Prepare Oncology Practices for July Launch of Oncology Care Model (OCM)

    Keywords: US Oncology Network, Press Release, Providers, US Oncology

  • June 02, 2016

    Virginia Cancer Specialists Receives 2016 Governor’s Volunteerism and Community Service Award for Small Business Category

    Keywords: US Oncology Network, Press Release, Providers

  • June 01, 2016

    ASCO Annual Meeting: The US Oncology Network and US Oncology Research Affiliated Investigators to Showcase Clinical Study Results From 30 Abstracts

    Keywords: US Oncology Network, Press Release, Providers, US Oncology

  • May 25, 2016

    McKesson Driving Success of Independent Pharmacy

    Keywords: Press Release, Health Mart, Health Mart, Pharmaceutical Distribution, Pharmacies

  • May 25, 2016

    McKesson Declares Quarterly Dividend May 25, 2016

    Keywords: Press Release, Investors, Corporate

  • May 16, 2016

    McKesson and Walmart Announce Sourcing Agreement for Generic Pharmaceuticals

    Keywords: Press Release, Corporate

  • May 09, 2016

    Texas Center for Proton Therapy Treats First Patient with Isocentric Cone Beam CT and Pencil Beam Scanning

    Keywords: US Oncology Network, Press Release, Providers, US Oncology

  • May 05, 2016

    McKesson Specialty Health Solution Helps Community-Based Cancer Care Providers Participate in the Oncology Care Model

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, US Oncology

  • May 04, 2016

    McKesson Reports Fiscal 2016 Fourth-Quarter and Full-Year Results

    Keywords: Press Release, Earnings, Investors, Corporate

  • May 03, 2016

    McKesson Recognized for Technology Innovation on InformationWeek’s 2016 “Elite 100” List

    Keywords: Press Release, Pharmaceutical Distribution, Manufacturers, Corporate

  • April 28, 2016

    McKesson Specialty Health’s iKnowMed℠ Earns Highest KLAS Ratings in Key Performance Categories

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Electronic Health Records

  • April 25, 2016

    McKesson to Deliver Keynote Address at eyeforpharma Philadelphia 2016

    Keywords: Press Release, Pharmacies

  • April 20, 2016

    McKesson Corporation to Present at the Bank of America Merrill Lynch 2016 Health Care Conference

    Keywords: Press Release, Investors, Corporate

  • April 18, 2016

    McKesson Patient Relationship Solutions a Finalist for eyeforpharma Philadelphia Awards 2016

    Keywords: Press Release, Pharmacies

  • April 13, 2016

    McKesson Corporation Fiscal 2016 Fourth Quarter Conference Call Scheduled for May 4, 2016

    Keywords: Press Release, Earnings, Investors, Corporate

  • April 13, 2016

    The US Oncology Network Annual Conference Empowers Oncologists to Prepare for Value-Based Care

    Keywords: US Oncology Network, Press Release, Providers, US Oncology

  • April 05, 2016

    McKesson & Gift of Life Bone Marrow Registry Drive Tops 2,000 to Save Lives

    Keywords: Press Release, Corporate

  • April 04, 2016

    McKesson Completes the Acquisitions of Vantage Oncology and Biologics

    Keywords: Press Release, Corporate

  • March 30, 2016

    Blue Cross and Blue Shield of Illinois and Illinois Cancer Specialists Announce First Oncology Intensive Medical Home Pilot in the State

    Keywords: US Oncology Network, Press Release, US Oncology

  • March 29, 2016

    Missouri Cancer Associates Adds New APRN to Enhance Patient Care and Expand Survivorship Programs

    Keywords: US Oncology Network, Press Release, US Oncology

  • March 22, 2016

    Florida Cancer Affiliates First in the State Certified to Offer New Spacing Device to Benefit Prostate Cancer Patients

    Keywords: US Oncology Network, Press Release, Providers, US Oncology

  • March 15, 2016

    Arizona Oncology Ranked Number One in Community-Based Cancer Care and Among the Top Two Statewide Cancer Care Centers

    Keywords: US Oncology Network, Press Release, Providers, US Oncology

  • March 14, 2016

    Missouri Cancer Associates and Urology Associates of Central Missouri to Participate in Boone Hospital Center’s Cancer Fair

    Keywords: US Oncology Network, Press Release, Providers, US Oncology

  • March 08, 2016

    Physicians with Florida Cancer Affiliates Honored For Contributions to Clinical Research

    Keywords: US Oncology Network, Press Release, Providers, US Oncology

  • March 02, 2016

    Urology Associates of Central Missouri Adds Another Urologist to Meet Growing Demand for Advanced Urologic Services

    Keywords: US Oncology Network, Press Release, US Oncology

  • March 02, 2016

    McKesson to Acquire Rexall Health from Katz Group, Strengthens its Position in Canada's Pharmaceutical Supply Chain

    Keywords: Press Release, Corporate

  • March 01, 2016

    Virginia Cancer Specialists Urges Men and Women to Get Screened During Colorectal Cancer Awareness Month

    Keywords: US Oncology Network, Press Release, Providers, US Oncology

  • February 29, 2016

    McKesson Pledges Support for Patient-Centered Interoperability

    Keywords: Press Release, Providers, Corporate

  • February 25, 2016

    McKesson Expands Oncology Expertise with the Acquisitions of Vantage Oncology and Biologics

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Corporate

  • February 24, 2016

    McKesson Launches NEW Drug Spend Intelligence Tool

    Keywords: Press Release, McKesson U.S. Pharmaceutical, Consumers, Pharmaceutical Distribution

  • February 24, 2016

    iKnowMed Recognized for Fifth Consecutive Year as Top-performing Electronic Health Record (EHR)

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Consumers, Electronic Health Records

  • February 22, 2016

    The US Oncology Network Launches Program to Help Prepare for Value-Based Alternative Payment Models

    Keywords: US Oncology Network, Press Release, US Oncology

  • February 19, 2016

    McKesson Launches PATH Pro™ Post-Acute Therapeutics Formulary Management Program for LTC Pharmacies

    Keywords: Press Release, McKesson U.S. Pharmaceutical, Pharmacies

  • February 17, 2016

    McKesson AccessHealth® Expands Its Suite of Reimbursement and Performance Enhancement Tools

    Keywords: Press Release, McKesson U.S. Pharmaceutical, Providers, Pharmacies

  • February 17, 2016

    McKesson Specialty Health Solution Center Wins Prestigious Award in Big Business Category

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, Pharmacies, Manufacturers

  • February 16, 2016

    Macro Helix’s 340B Architect Receives Best in KLAS Recognition as 2015/2016 Category Leader for 340B Management Systems

    Keywords: Press Release, McKesson U.S. Pharmaceutical, Consumers, Pharmaceutical Distribution

  • February 04, 2016

    US Oncology Research Translational Oncology Program Enrolls 2,000th Patient in Leading-Edge Phase I Clinical Trials

    Keywords: US Oncology Network, Press Release, Providers, US Oncology

  • January 29, 2016

    McKesson Releases FY2015 Corporate Citizenship Report

    Keywords: Press Release, Consumers, Corporate

  • January 27, 2016

    McKesson Declares Quarterly Dividend January 2016

    Keywords: Press Release, Investors, Corporate

  • January 27, 2016

    McKesson Reports Fiscal 2016 Third Quarter Results

    Keywords: Press Release, Earnings, Corporate

  • January 25, 2016

    McKesson Launches Clinical Programs Solution

    Keywords: Press Release, Pharmacies, McKesson Pharmacy Systems

  • January 20, 2016

    McKesson Corporation to Present at the Leerink Partners 5th Annual Global Healthcare Conference

    Keywords: Press Release, Investors, Corporate

  • January 14, 2016

    McKesson Specialty Health’s Reimbursement, Access & Safety Services Solution Center Named Center of Excellence

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Manufacturers

  • January 11, 2016

    McKesson Announces Fiscal 2016 Earnings Update and Preliminary Fiscal 2017 Outlook

    Keywords: Press Release, Earnings, Investors, Corporate

  • January 05, 2016

    McKesson Corporation Fiscal 2016 Third Quarter Conference Call Scheduled for January 27, 2016

    Keywords: Press Release, Earnings, Investors, Corporate

  • December 23, 2015

    McKesson Recommends Shareholders Reject "Mini-Tender" Offer by TRC Capital Corporation

    Keywords: Press Release, Corporate

  • December 22, 2015

    McKesson Corporation to Present at 34th Annual J.P. Morgan Healthcare Conference

    Keywords: Press Release, Corporate

  • December 15, 2015

    Virginia Cancer Specialists Adds New Medical Oncologists and Services for Rare Musculoskeletal Conditions

    Keywords: US Oncology Network, Press Release, US Oncology

  • December 09, 2015

    McKesson Specialty Health Hosts 2015 Onmark Select Program Fall Leadership Summit For Community-Based Oncology Practices

    Keywords: McKesson Specialty Health and US Oncology Network, Press Release, Providers, US Oncology

  • December 07, 2015

    McKesson Pharmacy Optimization® Team Identifies Five Health System Pharmacy Trends to Watch in 2016

    Keywords: Press Release, McKesson U.S. Pharmaceutical, Providers, Pharmacies, Healthcare Providers

  •  
  • 1
  • 2
  •  
  • McKesson logo
  • LOGINS
  • About McKesson
  • About Us
  • Our Values
  • Contact Us
  • McKesson Foundation
  • Sustainability and ESG
  • Our Leadership
  • Public Affairs
  • Newsroom
  • Connect with McKesson on Social Media
  • Careers
  • Find A Job
  • Student Opportunities
  • Diversity, Equity & Inclusion
  • Popular Solutions
  • Medical Supplies
  • Pharmaceutical Distribution
  • Specialty Drug Distribution
  • Health Mart Independent Pharmacy
  • Pharmacy Services & Technology
  • Oncology Ecosystem
  • Resources
  • Biopharma Resources
  • Health System Resources
  • Pharmacy Management Resources
  • Explainer: Biosimilars
  • Explainer: Medication Dispensing
  • Customer Ordering
  • Pharmaceuticals: Branded & Generic
  • Specialty and Oncology Drugs
  • Medical Supplies & Equipment
  • Homecare Products for Consumers
  • Investors
  • Financials
  • Financial News
  • Events & Presentations
  • Stock Information
  • Corporate Governance
  • Investor Resources
  • Our Businesses
  • U.S. Pharmaceutical
  • Medical-Surgical
  • Specialty Health
  • Pharmacy Systems
  • Prescription Automation
  • CoverMyMeds
  • McKesson International
  • McKesson Canada
  • McKesson Ventures
  • Contact Us
  • Privacy Notice
  • Do Not Sell My Information
  • Cookie Settings
  • Disclaimer
  • Patents
  • Cybersecurity
  • Site Map

© 2023 McKesson Corporation

  • facebook
  • linkedin
  • twitter
  • Instagram

top

  • About Us
  • Our Stories
  • Careers
  • Investors
  • Contact Us
  • Logins

close